DTL
ABCL icon

Dynamic Technology Lab’s AbCellera Biologics ABCL Stock Holding History

Dynamic Technology Lab’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-29,112
Closed -$86K – 969
2024
Q2 		$86K Buy
+29,112
New +$110K 0.01% 859
2023
Q1 		– Sell
-32,546
Closed -$329K – 1027
2022
Q4 		$329K Buy
32,546
+3,557
+12% +$41.1K 0.03% 737
2022
Q3 		$286K Buy
+28,989
New +$318K 0.03% 823
2022
Q2 		– Sell
-31,427
Closed -$306K – 1064
2022
Q1 		$306K Buy
+31,427
New +$298K 0.04% 779

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dynamic Technology Lab's ABCL Position: Q3 2024 in Review

Dynamic Technology Lab sold out of AbCellera Biologics (ABCL) in Q3 2024, closing a stake of 29,112 shares — an estimated $86K sold.

Dynamic Technology Lab first reported a position in ABCL in Q1 2022 and held it in 4 quarters. The position peaked at $329K in Q4 2022. 139 funds tracked by Wall St. Rank hold ABCL as of Q3 2024.

  • Dynamic Technology Lab reported no remaining AbCellera Biologics position as of Q3 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 29,112 AbCellera Biologics shares in Q3 2024, an estimated $86K.
  • Dynamic Technology Lab first reported a position in AbCellera Biologics in Q1 2022 and held it in 4 quarters.
  • Dynamic Technology Lab's AbCellera Biologics position peaked at $329K in Q4 2022.
  • 139 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2024.

Based on Dynamic Technology Lab's 13F filing for Q3 2024, filed 13 Nov 2024.